Daily Oncology News

St. John's wort: natural does not necessarily mean safe

St. John's wort: natural does not necessarily mean safe

Adverse reactions to St. John's Wort were similar to those reported for fluoxetine.

No association between opioids, breast cancer recurrence

No association between opioids, breast cancer recurrence

There is no clinically relevant evidence of an association between opioid prescriptions and breast cancer recurrence.

Researchers, providers need to address cancer health care disparities in LGBTQ community

Researchers, providers need to address cancer health care disparities in LGBTQ community

Adults in the LGBTQ community tend to be lower economic status and seek health care less often.

Omega-3 fatty acids improve quality of life, outcomes in cancer

Omega-3 fatty acids improve quality of life, outcomes in cancer

Addition of omega-3 fatty acids to anti-cancer medications may improve quality of life and treatment outcomes in patients with cancer.

ASCO: More Cancer Trials to Include More Seniors

ASCO: More Cancer Trials to Include More Seniors

ASCO has called on the U.S. government and the cancer research community to broaden clinical trials to include older adults.

In breast cancer survivors, lidocaine may relieve pain during intercourse

In breast cancer survivors, lidocaine may relieve pain during intercourse

Breast cancer survivors who experience pain or discomfort during sexual intercourse may benefit from applying liquid lidocaine to the vulvar area.

Many young patients with cancer may not be informed of fertility preservation options

Many young patients with cancer may not be informed of fertility preservation options

Many young patients with cancer may have limited knowledge of fertility preservation options.

For patients with terminal cancer, chemotherapy does not improve quality of life

For patients with terminal cancer, chemotherapy does not improve quality of life

Chemotherapy administered to patients with cancer who are near death does not improve quality of life.

Generic meds may boost survival in some early breast cancers

Generic meds may boost survival in some early breast cancers

More evidence that two classes of generic drugs (aromatase inhibitors and bisphosphonates) reduce the risk of death in early breast cancer.

More patients with prostate cancer being treated appropriately based on risk

More patients with prostate cancer being treated appropriately based on risk

Patients with prostate cancer are now more likely to receive medical care matched to risk level.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs